LTR Pharma Ltd (LTP) — Cash Flow-to-Debt Ratio
LTR Pharma Ltd (LTP) has a Cash Flow-to-Debt Ratio of -5.52x as of December 2024, meaning its operating cash flow of AU$-2.39 Million could theoretically repay -6% of its total liabilities (AU$433.33K) in one year. Explore LTR Pharma Ltd (LTP) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
LTR Pharma Ltd Cash Flow-to-Debt Ratio (2022–2024)
Historical debt coverage capacity for LTR Pharma Ltd across 3 annual periods. Also explore LTR Pharma Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for LTR Pharma Ltd (2022–2024)
Year-by-year debt coverage analysis for LTR Pharma Ltd. For market capitalisation and broader financial context, see LTP market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -11.88x | AU$-5.09 Million | AU$428.54K | ▲ +83.5% |
| 2023 | -72.23x | AU$-1.54 Million | AU$21.26K | ▼ -5949.7% |
| 2022 | -1.19x | AU$-568.18K | AU$475.91K | — |